arrow
K

Keito Suto

hokkaido university
H指数:4
被引数:87

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation

PLK1抑制通过激活有丝分裂纺锤体组装检验点增强Brentuximab vedotin对CD30阳性T细胞淋巴瘤的疗效

Leukemia
IF13.4
2026-07-130
PRE
Safety and efficacy of GVHD prophylaxis with mini-dose methotrexate in umbilical cord blood transplantation – NJHSG-CBT18 observational study –

GVHD预防中使用小剂量甲氨蝶呤在脐带血移植中的安全性与有效性——NJHSG-CBT18观察性研究

2025-11-060
PRE
Reduced FDG Uptake in the Brain on Baseline 18FDG PET/CT Predicts Worse Prognosis of Newly Diagnosed Intravascular Large B-Cell Lymphoma and Advanced-Stage Diffuse Large B-Cell Lymphoma

基线18FDG PET/CT上脑部FDG摄取降低预测新诊断的血管内大B细胞淋巴瘤和晚期弥漫性大B细胞淋巴瘤的不良预后

BLOOD
IF23.1
2024-11-050
PRE
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group
2024-06-130
OAAI